Skip to main content

New Products: Apr 5, 2011 (rev. 1)

Premium

Abbott Molecular has launched its CE-Marked Abbott HBV Sequencing test in the European Union. The test is the first sequencing-based diagnostic to be developed by Abbott, and was developed on Life Technologies' CE 3130 DNA sequencing system.

According to the company, the test identifies the DNA sequence of the hepatitis B virus polymerase gene, including all clinically relevant HBV drug resistant mutations.

This molecular diagnostic test was developed to help physicians monitor HBV infections, guide treatment decisions, and predict or discover drug resistance. It is not intended for screening blood donors, plasma, or tissue donors for HBV, or to be used as a diagnostic test to confirm the presence of HBV infection, Abbott said.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.